Should diuretics be first line for hypertension?
نویسندگان
چکیده
منابع مشابه
Should -blockers and diuretics remain as first line therapy for hypertension? Thiazide-Type Diuretics and -Adrenergic Blockers as First-Line Drug Treatments for Hypertension
Systemic arterial hypertension affects 72 million US adults and an additional hundreds of millions of persons worldwide.1,2 Most of these are candidates for pharmacological treatment to reduce risk of cardiovascular disease (CVD) events, based primarily on a very large body of epidemiological and intervention research in humans. Because of this high prevalence and the cardiovascular consequence...
متن کاملShould atenolol still be recommended as first-line therapy for primary hypertension?
antihypertensive treatment should reduce the incidence of cardiovascular morbidity and mortality as well as total mortality. For four decades, beta-blockers have been widely used for the treatment of hypertension and are still proposed as first-line drugs in national and international guidelines. Numerous prospective, randomised studies have established beyond any doubt the efficacy of beta-blo...
متن کاملShould ablation be the first line treatment for supraventricular arrhythmias?
Catheter ablation remains a good first line choice for the palliative treatment of symptomatic typical atrial flutter.
متن کاملShould hypertension be treated with angiotensin-converting-enzyme inhibitors, calcium-channel blockers or diuretics?
متن کامل
Should atrial fibrillation ablation be considered first-line therapy for some patients? Why Atrial Fibrillation Ablation Should Be Considered First-Line Therapy for Some Patients
Atrial fibrillation (AF) is an increasingly common disease that affects patient morbidity and mortality. To date, treatments of AF have been frustrating, serving at best to palliate this arrhythmia. AF ablation, on the other hand, has emerged as a promising new treatment strategy. In contrast to rate control or antiarrhythmic drugs, ablation offers the possibility of a lasting cure. When ablati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacy Today
سال: 2020
ISSN: 1042-0991
DOI: 10.1016/j.ptdy.2019.12.005